We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-14.06%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.24B
AUM Growth
-$98.1M
(-7.4%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
11.27%
Top 10 Holdings %
Top 10 Hldgs %
39.9%
Holding
2,819
New
365
Increased
978
Reduced
847
Closed
217
Avg Time Held Equity + Options
2.1
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
1.5
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVB Financial
CVBF
|
+$78.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$48.7M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$16.1M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$10.8M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$8.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$13.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$7.79M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.79M |
| 4 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$6.62M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.43% |
| 2 | Technology | 12.95% |
| 3 | Financials | 11.18% |
| 4 | Healthcare | 5.67% |
| 5 | Consumer Discretionary | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
iShares Russell 2000 Growth ETF
IWO
$13.7B
| $551K | 0.04% |
3,485
-77
| -2% | -$15.3K |
2016 Q4
13 quarters
|
|
227
Union Pacific
UNP
$172B
| $551K | 0.04% |
3,915
-447
| -10% | -$73.9K |
2016 Q4
13 quarters
|
|
228
Ameren
AEE
$28.7B
| $539K | 0.04% |
7,407
+859
| +13% | +$68.1K |
2016 Q4
13 quarters
|
|
229
Clorox
CLX
$10.4B
| $538K | 0.04% |
3,107
+1,897
| +157% | +$313K |
2016 Q4
13 quarters
|
|
230
AstraZeneca
AZN
$259B
| $537K | 0.04% |
6,017
+424
| +8% | +$39.9K |
2016 Q4
13 quarters
|
|
231
Cummins
CMI
$73.3B
| $535K | 0.04% |
3,954
-191
| -5% | -$29.8K |
2016 Q4
13 quarters
|
|
232
CBRE Group
CBRE
$39.2B
| $533K | 0.04% |
14,148
-6,383
| -31% | -$353K |
2016 Q4
13 quarters
|
|
233
CME Group
CME
$104B
| $527K | 0.04% |
3,052
-332
| -10% | -$66.1K |
2016 Q4
13 quarters
|
|
234
iShares Gold Trust
IAU
$61.9B
| $526K | 0.04% |
17,483
+219
| +1% | +$6.62K |
2016 Q4
13 quarters
|
|
235
Baxter International
BAX
$13.3B
| $516K | 0.04% |
6,363
+527
| +9% | +$45.5K |
2016 Q4
13 quarters
|
|
236
American Electric Power
AEP
$67.7B
| $512K | 0.04% |
6,402
+633
| +11% | +$59.9K |
2016 Q4
13 quarters
|
|
237
Humana
HUM
$51.9B
| $512K | 0.04% |
1,633
+128
| +9% | +$43.2K |
2016 Q4
13 quarters
|
|
238
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.7B
| $511K | 0.04% |
11,409
-3,539
| -24% | -$197K |
2016 Q4
13 quarters
|
|
239
Invesco Large Cap Growth ETF
PWB
$2.63B
| $509K | 0.04% |
11,645
-1,250
| -10% | -$62.2K |
2019 Q1
4 quarters
|
|
|
CERN
240
DELISTED
Cerner Corp
CERN
| $507K | 0.04% |
8,056
+2,608
| +48% | +$185K |
2016 Q4
13 quarters
|
|
241
Constellation Brands
STZ
$21.9B
| $505K | 0.04% |
3,529
-3,125
| -47% | -$551K |
2016 Q4
13 quarters
|
|
242
Corteva
CTVA
$8.59B
| $501K | 0.04% |
21,329
-2,638
| -11% | -$72.5K |
2019 Q3
2 quarters
|
|
243
Moody's
MCO
$83.8B
| $497K | 0.04% |
2,354
+478
| +25% | +$116K |
2016 Q4
13 quarters
|
|
244
Essex Property Trust
ESS
$17.3B
| $494K | 0.04% |
2,247
+93
| +4% | +$26.7K |
2016 Q4
13 quarters
|
|
245
CoStar Group
CSGP
$13B
| $492K | 0.04% |
8,390
+900
| +12% | +$58.7K |
2016 Q4
13 quarters
|
|
246
Newmont
NEM
$122B
| $492K | 0.04% |
10,877
+4,327
| +66% | +$195K |
2016 Q4
13 quarters
|
|
247
ASML
ASML
$637B
| $488K | 0.04% |
1,867
-58
| -3% | -$16.5K |
2016 Q4
13 quarters
|
|
248
Kimberly-Clark
KMB
$34.6B
| $484K | 0.04% |
3,788
+1,201
| +46% | +$166K |
2016 Q4
13 quarters
|
|
249
Phillips 66
PSX
$115B
| $484K | 0.04% |
9,022
-2,306
| -20% | -$188K |
2016 Q4
13 quarters
|
|
250
Booz Allen Hamilton
BAH
$8.96B
| $482K | 0.04% |
7,035
+534
| +8% | +$39.4K |
2017 Q3
10 quarters
|
|
Similar funds
Parallel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Parallel Advisors held 2,819 positions worth $1.24B, down 7.4% from $1.33B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Parallel Advisors deployed $139M of net new capital in Q1 2020, opening 365 new positions and adding to 978 existing holdings. Its largest new stake was Adverum Biotechnologies: 5,766 shares worth $563K.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 59% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $13.1M trimmed.
- Parallel Advisors's largest Q1 2020 buy was Adverum Biotechnologies: 5,766 shares worth $563K.
- Parallel Advisors added most to CVB Financial in Q1 2020, an estimated $78.5M increase.
- Parallel Advisors's biggest Q1 2020 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $13.1M.
- Parallel Advisors fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q1 2020, selling an estimated $1.38M.
- Parallel Advisors's ten largest holdings make up 40% of its $1.24B portfolio in Q1 2020.
- Parallel Advisors opened 365 new positions and closed 217 in Q1 2020.
- Parallel Advisors's portfolio value fell 7.4% quarter-over-quarter to $1.24B.
Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.